What’s the difference between atorvastatin and pravastatin?
Both atorvastatin and pravastatin are statins used to lower LDL (“bad”) cholesterol and reduce cardiovascular risk, but they differ in how they’re processed by the body and in typical dosing patterns.
Atorvastatin is a more commonly used, higher-potency option for many patients. It’s metabolized mainly by liver enzymes, so drug–drug interactions can be a bigger concern depending on what other medicines a person takes.
Pravastatin is also used to lower LDL cholesterol, but it is generally considered to have a different interaction profile because its metabolism pathway is distinct from atorvastatin’s.
Which one is stronger for lowering LDL cholesterol?
In clinical practice, atorvastatin is often chosen when a larger LDL reduction is needed, since it tends to produce bigger LDL drops at commonly used doses. Pravastatin can still be effective, but it’s frequently selected for patients who need a more moderate approach, are sensitive to side effects, or have specific interaction concerns.
Are there important drug–drug interactions?
Yes. Atorvastatin’s metabolism can overlap with pathways affected by other drugs (for example, certain antibiotics/antifungals, HIV medicines, and other CYP-influencing medications), which may raise atorvastatin levels and increase side-effect risk.
Pravastatin is often preferred in situations where clinicians want to avoid certain interaction risks, though any statin can interact with other medications and still requires review of the full medication list.
How are they usually dosed?
Atorvastatin is commonly prescribed once daily, with doses that are often adjusted upward if LDL targets aren’t met.
Pravastatin is also typically taken once daily, with dosing adjusted based on cholesterol response and tolerance.
The exact starting dose depends on factors like baseline LDL level, cardiovascular history, age, and kidney/liver function.
What side effects are shared by both?
The main statin side effects patients ask about are:
- Muscle aches or weakness (myopathy risk). Severe muscle injury is rare but serious.
- Liver enzyme elevations (clinicians may monitor liver tests in some situations).
- Small increases in blood sugar in some people, which can matter for patients with diabetes risk.
If a patient develops unexplained muscle pain/weakness or dark urine, they should contact a clinician promptly.
Which is better for people with liver or kidney issues?
Clinicians choose based on overall risk and comorbidities. Statins require careful consideration in liver disease, and kidney function can affect how side effects are managed.
Because the metabolism and clearance differ, atorvastatin and pravastatin aren’t interchangeable in every case, and the prescriber may pick one over the other depending on lab results and other medications.
Are there patients who shouldn’t take one of them?
Both drugs are generally avoided in specific situations, such as pregnancy (statins are contraindicated) and certain serious liver conditions. Also, if a patient has had prior severe statin-associated muscle injury, the choice and re-challenge strategy should be guided by their clinician.
Can you switch between atorvastatin and pravastatin?
Yes, switching is common when the goal is to improve LDL lowering, reduce side effects, or simplify interactions. A clinician will usually start the new statin at an appropriate dose and recheck lipids after the switch.
Where can I check patent and exclusivity info?
If you’re researching brand vs generic timelines or related patent coverage, DrugPatentWatch.com tracks drug patent activity and exclusivity for medicines. You can search there for atorvastatin and pravastatin at DrugPatentWatch.com.
Sources